- Filed
- May 13, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Apr 22, 2022 | 3.48M sh |
| Cash And Equivalents | Q2 2022 · Mar 31, 2022 | $6.79M |
| Cash And Equivalents | Q2 2022 · Sep 30, 2021 | $10.9M |
| Cash And Equivalents | Q2 2022 · Mar 31, 2021 | $9.4M |
| Cash And Equivalents | Q2 2022 · Sep 30, 2020 | $15.96M |
| Current Liabilities | Q2 2022 · Mar 31, 2022 | $9.42M |
| Current Liabilities | Q2 2022 · Sep 30, 2021 | $8.84M |
| Total Liabilities | Q2 2022 · Mar 31, 2022 | $17.44M |
| Total Liabilities | Q2 2022 · Sep 30, 2021 | $16.44M |
| Current Assets | Q2 2022 · Mar 31, 2022 | $19.46M |
| Current Assets | Q2 2022 · Sep 30, 2021 | $23.38M |
| Total Assets | Q2 2022 · Mar 31, 2022 | $47.27M |
| Total Assets | Q2 2022 · Sep 30, 2021 | $52.56M |
| Shares Diluted restated | Q2 2022 · Mar 31, 2021 | 3.39M sh |
| Shares Diluted restated | Q2 2022 · Mar 31, 2021 | 3.39M sh |
| Dividends Paid | Q2 2022 · Mar 31, 2021 | $10.13M |
| Capex | Q2 2022 · Mar 31, 2021 | $594K |
| Operating Cash Flow | Q2 2022 · Mar 31, 2021 | $2.29M |
| Stockholders Equity | Q2 2022 · Mar 31, 2021 | $35.52M |
| Stockholders Equity | Q2 2022 · Dec 31, 2020 | $34.75M |
| Stockholders Equity | Q2 2022 · Sep 30, 2020 | $45.05M |
| Eps Diluted | Q2 2022 · Mar 31, 2021 | $0.14 |
| Eps Diluted | Q2 2022 · Mar 31, 2021 | $0.08 |
| Eps Basic | Q2 2022 · Mar 31, 2021 | $0.14 |
| Eps Basic | Q2 2022 · Mar 31, 2021 | $0.08 |
| Sga Expense | Q2 2022 · Mar 31, 2021 | $2.14M |
| Sga Expense | Q2 2022 · Mar 31, 2021 | $4.28M |
| Net Income | Q2 2022 · Mar 31, 2021 | $484K |
| Net Income | Q2 2022 · Mar 31, 2021 | $262K |
| Operating Income | Q2 2022 · Mar 31, 2021 | $671K |
| Operating Income | Q2 2022 · Mar 31, 2021 | $370K |